Cargando…
P1353: EXPLORING A NOVEL TREATMENT STRATEGY FOR ACQUIRED APLASTIC ANEMIA TARGETING PPAR SIGNALING PATHWAY.
Autores principales: | Yang, Liping, Cao, Qiuying, Shao, Zonghong, Wang, Huaquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430458/ http://dx.doi.org/10.1097/01.HS9.0000972300.55619.05 |
Ejemplares similares
-
Aplastic Anemia in China
por: Liu, Chunyan, et al.
Publicado: (2018) -
The Clinical and Immune Characteristics of Patients with Hepatitis-Associated Aplastic Anemia in China
por: Wang, Huaquan, et al.
Publicado: (2014) -
Abnormal expression of histone acetylases in CD8+ T cells of patients with severe aplastic anemia
por: Qi, Weiwei, et al.
Publicado: (2022) -
Abnormal Proteomics Profile of Plasma Reveals the Immunological Pathogenesis of Severe Aplastic Anemia
por: Qi, Weiwei, et al.
Publicado: (2022) -
Myeloid dendritic cells in severe aplastic anemia patients exhibit stronger phagocytosis
por: Sun, Yingying, et al.
Publicado: (2021)